I was wondering if Durrant reconfirmed the 100,000 patient projection that he made March 29th. Because $51.4 million sounds like it would produce more than 100,000 treatments. IIRC, leronflimflam costs $40 to manufacture each dose. $40 divided into $51.4 million is 1.2 million doses. My guess is that lenzilumab costs more to produce but how much more?